Zoetis plans cautiously for 2027 as pet owners cut back on vet visits, shares fall

Zoetis (ZTS) reported Q3 2026 results with revenue and adjusted net income declining as expected. The company narrowed its 2026 revenue outlook to $9.22B-$9.32B and raised adjusted EPS guidance to $6.25-$6.35. CEO Kristin Peck noted challenging dynamics persist.

Zoetis (ZTS) reported Q3 2026 earnings with revenue and adjusted net income declining as expected. The company cited challenges in pet care due to rising costs and changing pet ownership trends, while livestock demand remains strong. Zoetis narrowed its full-year revenue guidance to the high end of its range and highlighted investments in key franchises and innovation.

Zoetis reported 3Q 2026 revenue of $2.39B, down 1% YoY, and net income of $1.44B, down 18%. Declines were driven by softer U.S. companion-animal demand, competition, and lower prices, partially offset by livestock growth and favorable exchange rates. Higher restructuring costs also impacted earnings. U.S. companion-animal revenue fell 8%, while U.S. livestock and international revenues rose 5% and 4%, respectively.

Zoetis (ZTS) stock rose 2.4% premarket after Q3 2026 earnings beat estimates, with adjusted EPS of $1.75 vs. $1.51 and revenue of $2.4B vs. $2.3B. The company raised full-year EPS guidance to $6.25–$6.35. International sales grew 4%, while U.S. companion animal business faced challenges. The stock traded near $91.30 premarket, below its 52-week high of $132.49.

Zoetis (ZTS) reported Q3 adjusted earnings of $1.75 per share on $2.39B in sales, beating analyst estimates. This compares to $1.70 per share on $2.42B in sales a year earlier. The company's stock rose early Thursday following the announcement.

Zoetis (ZTS) reported Q3 2026 revenue of $2.39B, exceeding estimates by 2.6% and EPS of $1.75, beating estimates by 15.8%. The company raised its full-year revenue guidance to $9.27B and adjusted EPS guidance to $6.30.